page contents

Tag Archives: Rating

BLUCORA INC Common Stock (NASDAQ:BCOR) had its Buy rating reiterated by Barrington Research with a $41.00 price target

BLUCORA INC Common Stock (NASDAQ:BCOR) had its Buy rating reiterated by Barrington Research with a $ 41.00 price target Mar 20, 2019 (Market Exclusive via COMTEX) — Analyst Ratings For BLUCORA INC Common Stock (NASDAQ:BCOR) Today, Barrington Research reiterated its Buy rating on BLUCORA INC Common Stock (NASDAQ:BCOR) with a price target of $ 41.00. There are 5 Buy Ratings, ...

Read More »

This Stock Hitting a 52-Week Low Has a Strong Sell Rating Right Now

This Stock Hitting a 52-Week Low Has a Strong Sell Rating Right Now With a strong sell signal indicating a stock that has finally gone into freefall after months of undervaluation, let’s take a deep dive through the data for Transcontinental (TSX:TCL.A) and weigh the options are for investors or would-be shareholders in this hitherto desirable ticker. Indeed, there is ...

Read More »

Fennec Pharmaceuticals Inc (NASDAQ:FENC) had its Outperform rating reiterated by Wedbush with a $16.00 price target

Fennec Pharmaceuticals Inc (NASDAQ:FENC) had its Outperform rating reiterated by Wedbush with a $ 16.00 price target Mar 14, 2019 (Market Exclusive via COMTEX) — Analyst Ratings For Fennec Pharmaceuticals Inc (NASDAQ:FENC) Today, Wedbush reiterated its Outperform rating on Fennec Pharmaceuticals Inc (NASDAQ:FENC) with a price target of $ 16.00. There are 4 Buy Ratings, no Strong Buy Ratings, no ...

Read More »

Fennec Pharmaceuticals Inc (NASDAQ:FENC) had its Outperform rating reiterated by Wedbush with a $16.00 price target

Fennec Pharmaceuticals Inc (NASDAQ:FENC) had its Outperform rating reiterated by Wedbush with a $ 16.00 price target Mar 14, 2019 (Market Exclusive via COMTEX) — Analyst Ratings For Fennec Pharmaceuticals Inc (NASDAQ:FENC) Today, Wedbush reiterated its Outperform rating on Fennec Pharmaceuticals Inc (NASDAQ:FENC) with a price target of $ 16.00. There are 4 Buy Ratings, no Strong Buy Ratings, no ...

Read More »

Fennec Pharmaceuticals Inc (NASDAQ:FENC) had its Outperform rating reiterated by Wedbush with a $16.00 price target

Fennec Pharmaceuticals Inc (NASDAQ:FENC) had its Outperform rating reiterated by Wedbush with a $ 16.00 price target Mar 14, 2019 (Market Exclusive via COMTEX) — Analyst Ratings For Fennec Pharmaceuticals Inc (NASDAQ:FENC) Today, Wedbush reiterated its Outperform rating on Fennec Pharmaceuticals Inc (NASDAQ:FENC) with a price target of $ 16.00. There are 4 Buy Ratings, no Strong Buy Ratings, no ...

Read More »

Fennec Pharmaceuticals Inc (NASDAQ:FENC) had its Outperform rating reiterated by Wedbush with a $16.00 price target

Fennec Pharmaceuticals Inc (NASDAQ:FENC) had its Outperform rating reiterated by Wedbush with a $ 16.00 price target Mar 14, 2019 (Market Exclusive via COMTEX) — Analyst Ratings For Fennec Pharmaceuticals Inc (NASDAQ:FENC) Today, Wedbush reiterated its Outperform rating on Fennec Pharmaceuticals Inc (NASDAQ:FENC) with a price target of $ 16.00. There are 4 Buy Ratings, no Strong Buy Ratings, no ...

Read More »

Wilmington Trolley: Better Business Bureau's “F” rating unfair

[unable to retrieve full-text content] … release Tuesday, the Better Business Bureau of Coastal Carolina, … use caution when doing business with Wilmington Trolley Company … the Wilmington-based trolley business, and that Wilmington Trolley … does a brisk charter business, offering shuttles for such …… Business News

Read More »

Wilmington Trolley: Better Business Bureau's “F” rating unfair

[unable to retrieve full-text content] … release Tuesday, the Better Business Bureau of Coastal Carolina, … use caution when doing business with Wilmington Trolley Company … the Wilmington-based trolley business, and that Wilmington Trolley … does a brisk charter business, offering shuttles for such …… Business News

Read More »

BMC Stock Holdings Inc (NASDAQ:BMCH) had its Outperform rating reiterated by Wedbush with a $23.00 price target

BMC Stock Holdings Inc (NASDAQ:BMCH) had its Outperform rating reiterated by Wedbush with a $ 23.00 price target Mar 12, 2019 (Market Exclusive via COMTEX) — Analyst Ratings For BMC Stock Holdings Inc (NASDAQ:BMCH) Today, Wedbush reiterated its Outperform rating on BMC Stock Holdings Inc (NASDAQ:BMCH) with a price target of $ 23.00. There are 9 Hold Ratings, 4 Buy ...

Read More »

Aileron Therapeutics Inc (NASDAQ:ALRN) has coverage initiated with a Buy rating and $7.00 price target

Aileron Therapeutics Inc (NASDAQ:ALRN) has coverage initiated with a Buy rating and $ 7.00 price target Mar 11, 2019 (Market Exclusive via COMTEX) — Analyst Ratings For Aileron Therapeutics Inc (NASDAQ:ALRN) Today, HC Wainwright initiated coverage on Aileron Therapeutics Inc (NASDAQ:ALRN) with a Buy with a price target of $ 7.00. There are 1 Buy Ratings, no Strong Buy Ratings, ...

Read More »

By continuing to use the site, you agree to the use of cookies. more information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close